《Table 2 Mean/median BCVA and mean/median CMT according to time period following Iluvienimplant inse
提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes》
PPV:Pars plana vitrectomy;BCVA:Best-corrected visual acuity;CMT:Central macular thickness.
Patient demographics are summarized in Table 1.
图表编号 | XD0023068000 严禁用于非法目的 |
---|---|
绘制时间 | 2018.12.18 |
作者 | Alberto La Mantia、Alan Hawrami、Heidi Laviers、Sudeshna Patra、Hadi Zambarakji |
绘制单位 | Eye Treatment Centre, Whipps Cross University Hospital, Barts Health National Health System Foundation Trust、Eye Treatment Centre, Whipps Cross University Hospital, Barts Health National Health System Foundation Trust、Eye Treatment Centre, Whipps Cross Un |
更多格式 | 高清、无水印(增值服务) |
查看“Table 2 Mean/median BCVA and mean/median CMT according to time period following Iluvienimplant insertion in vitrectomize”的人还看了
- Table 6 Adverse events and infections in the study cohort listed according to the time of their occurrence